Variable surveyed | No of sera available | Antibody titre ≥64 | Antibody titre ≥128 |  | |||
---|---|---|---|---|---|---|---|
No of seropositive dogs (%; 95% CI) | OR; 95% CI | P value | No of positive dogs (%) | OR; 95% CI | P value | ||
Total sera in the study | 292 | 148 (50.7%) | 0.45 - 0.56 | Â | 54 (18.5%) | 0.14 - 0.23 | Â |
Location | Â | Â | Â | 0.360 | Â | Â | 0.947 |
SE QLD dogs | 185 | 90 (48.6%) | Reference | Â | 34 (18.4%) | Reference | Â |
NT dogs | 107 | 58 (54.2%) | 1.25; 0.78 – 2.01 |  | 20 (18.7%) | 1.02; 0.55 – 1.88 |  |
Source | Â | Â | Â | 0.510 | Â | Â | 0.221 |
Client-owned | 180 | 88 (48.9%) | Reference | Â | 29 (16.1%) | Reference | Â |
Pound | 100 | 53 (53.0%; ) | 1.18; 0.72 – 1.87 |  | 22 (22%) | 1.47; 0.79, 2.72 |  |
Status of active ectoparasite control | Â | Â | Â | 0.014 | Â | Â | 0.106 |
Active ectoparasite control | 42 | 12 (28.6%) | Reference | Â | 4 (9.5%) | Reference | Â |
No active ectoparasite control | 106 | 52 (49.1%) | 2.60; 1.20 - 5.56 | Â | 22 (20.8%) | 2.49; 0.80, 7.69 | Â |
Breed | Â | Â | Â | 0.265 | Â | Â | 0.286 |
Purebred | 142 | 67 (47.2%) | Reference | Â | 23 (16.2%) | Reference | Â |
Mixed breed | 147 | 79 (53.7%) | 1.30; 0.76 - 2.51 | Â | 31 (21.1%) | 1.38; 0.76, 2.51 | Â |
Age | Â | Â | Â | 0.298 | Â | Â | 0.128 |
Young (<1 year) | 58 | 25 (43.1%) | Reference | Â | 7 (12.7%) | Reference | Â |
Adult (1 – 10 year) | 192 | 101 (52.6%) | 1.37; 0.76 – 2.46 |  | 41 (21.4%) | 1.98; 0.84 – 4.69, | 0.121 |
Geriatric (>10year) | 37 | 18 (48.6) | 1.17; 0.51 – 2.67 |  | 4 (10.8%) | 0.88; 0.24 – 3.25 | 0.852 |
Gender | Â | Â | Â | 0.638 | Â | Â | 0.414 |
Male | 143 | 70 (49.0%) | Reference | Â | 29 (20.3%) | 1.28; 0.71, 2.33 | Â |
Female | 145 | 75 (51.7%) | 1.12; 0.70 – 1.77 |  | 24 (16.6%) | Reference |  |
Desexing status | Â | Â | Â | 0.032 | Â | Â | 0.062 |
Neutered | 111 | 48 | Reference | Â | 16 (14.4%) | Reference | Â |
Intact | 111 | 64 | 1.79; 1.05 – 3.04 |  | 27 (24.3%) | 1.91; 0.96 – 3.78 |  |